Malignant Cardiac Tumors: Diagnosis and Treatment

References

• Valente ML , RizzoS, LeoneO, BassoC . Primary malignant tumors of the heart . In : Cardiac Tumor Pathology . BassoC, ValenteML, ThieneG ( Eds ). Springer (Humana Press), New York, NY, USA, 73 – 89 ( 2013 ).
   Google Scholar
• Miguel CE , BestettiRB . Primary cardiac lymphoma . Int. J. Cardiol.149, 358 – 363 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Butany J , NaseemuddinA, NairGM, CattonC, YauT . Cardiac tumours: diagnosis and treatment . Lancet Oncol.6, 219 – 228 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Jain D , MaleszewskiJJ, HalushkaMK . Benign cardiac tumors and tumorlike conditions . Ann. Diagn. Pathol.14, 215 – 230 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Goswami KC , ShrivastavaS, BahlVK, SaxenaA, ManchandaSC, WasirHS . Cardiac myxomas: clinical and echocardiographic profile . Int. J. Cardiol.63, 251 – 259 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Mazzola A , SpanoJP, ValenteMet al. Leiomyosarcoma of the left atrium mimicking a left atrial myxoma . J. Thorac. Cardiovasc. Surg.131, 224 – 226 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Tao TY , Yahyavi-Firouz-AbadiN, SinghGK, BhallaS . Pediatric cardiac tumors: clinical and imaging features . Radiographics34, 1031 – 1046 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lestuzzi C , PiazzaR, PavanD, ComorettoM, NicolosiGL . Masse intracavitarie e paracardiache . In : Manuale di ecocardiografia clinica (Volume 2) . NicolosiGL, Antonini-CanterinF, PavanD, PiazzaR ( Eds ). Piccin Nuova Libraria S.p.APadova, Italy ( 2015 ).
   Google Scholar
• Lassau N , ChamiL, ChebilMet al. Dynamic contrast- enhanced ultrasonography (DCE-US) and anti-angiogenic treatments . Discov. Med.11 ( 56 ), 18 – 24 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Li SY , HuangPT, XuHSet al. Enhanced intensity on preoperative double contrast-enhanced sonography as a useful indicator of lymph node metastasis in patients with gastric cancer . J. Ultrasound Med.33, 1773 – 1781 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Peters PJ , ReinhardtS . The echocardiographic evaluation of intracardiac masses: a review . J. Am. Soc. Echocardiogr.19, 230 – 240 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Zaragoza-Macias E , ChenMA, GillEA . Real time three-dimensional echocardiography evaluation of intracardiac masses . Echocardiography29, 207 – 219 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Plana JC . Three-dimensional echocardiography in the assessment of cardiac tumors: the added value of the extra dimension . Methodist Debakey Cardiovasc. J.6, 12 – 19 ( 2010 ).
   PubMedGoogle Scholar
• Rajiah P , KanneJP, KalahastiV, SchoenhagenP . Computed tomography of cardiac and pericardiac masses . J. Cardiovasc. Comput. Tomogr.5, 16 – 29 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hoey E , GaneshanA, NaderK, RandhawaK, WatkinR . Cardiac neoplasms and pseudotumors: imaging findings on multidetector CT angiography . Diagn. Interv. Radiol.18, 67 – 77 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kassop D , DonovanMS, CheezumMKet al. Cardiac masses on cardiac CT: a review . Curr. Cardiovasc. Imaging Rep.7, 9281 ( 2014 ).
   PubMedGoogle Scholar
• Buckley O , MadanR, KwongR, RybickiFJ, HunsakerA . Cardiac masses, part 1: imaging strategies and technical considerations . AJR Am. J. Roentgenol.197, W837 – W841 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Randhawa K , GaneshanA, HoeyET . Magnetic resonance imaging of cardiac tumors: part 1, sequences, protocols, and benign tumors . Curr. Probl. Diagn. Radiol.40, 158 – 168 ( 2011 ).
   PubMedGoogle Scholar
• Bauner KU , SourbronS, PiccioloMet al. MR first pass perfusion of benign and malignant cardiac tumours-significant differences and diagnostic accuracy . Eur. Radiol.22, 73 – 82 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Attili AK , ChewFS . Imaging of cardiac masses and myocardial disease: self-assessment module . AJR Am. J. Roentgenol.188 ( 6 Suppl. ), S21 ( 2007 ).
   PubMedGoogle Scholar
• Pazos-López P , PozoE, SiqueiraMEet al. Value of CMR for the differential diagnosis of cardiac masses . JACC Cardiovasc. Imaging7 ( 9 ), 896 – 905 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Maurer AH , BurshteynM, AdlerLP, SteinerRM . How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT . Radiographics31 ( 5 ), 1287 – 1305 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Rahbar K , SeifarthH, SchäfersMet al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT . J. Nucl. Med.53, 856 – 863 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Benz MR , DrySM, EilberFCet al. Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET . J. Nucl. Med.51, 1174 – 1181 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Israel O , Weiler-SagieM, RisplerSet al. PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake . J. Nucl. Med.48, 234 – 239 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lin EC , AlaviA . Normal variants and benign findings . In : PET And PET/CT. A Clinical Guide (2nd Edition) . LinEC, AlaviA ( Eds ). Thieme, New York, NY, USA ( 2009 ).
   Google Scholar
• Korn RL , CoatesA, MillstineJ . The role of glucose and FDG metabolism in the interpretation of PET studies . In : PET And PET/CT. A Clinical Guide (2nd Edition) . LinEC, AlaviA ( Eds ). Thieme, New York, NY, USA ( 2009 ).
   Google Scholar
• Loft A , JensenKE, LöfgrenJ, DaugaardS, PetersenMM . PET/MRI for preoperative planning in patients with soft tissue sarcoma: a technical report of two patients . Case Rep. Med.2013, 791078 ( 2013 ).
   PubMedGoogle Scholar
• Nensa F , SchlosserT . Cardiovascular hybrid imaging using PET/MRI . Rofo86 ( 12 ), 1094 – 1101 ( 2014 ).
   Google Scholar
• Watanabe R . TomitaN, TakeuchiKet al. SUVmax in FDG-PET and the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma . Leuk. Lymph.51, 279 – 283 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• World Health Organization Classification Of Tumors: Pathology And Genetics Of Tumours Of The Lung, Pleura, Thymus And Heart . TrawisWD, BrambillaE, Muller-HermelinkHK, HarrisCC ( Eds ). ARC Press, Lyon, France, 250 ( 2004 ).
   Google Scholar
• Orlandi A , FerlosioA, RoselliM, ChiarielloL, SpagnoliLG . Cardiac sarcomas: an update . J. Thorac. Oncol.5, 1483 – 1489 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Neuville A , Ranchère-VinceD, Dei TosAPet al. Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European Epidemiological Study . Am. J. Surg. Pathol.37 ( 8 ), 1259 – 1268 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Neuville A , CollinF, BrunevalPet al. Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas . Am. J. Surg. Pathol.38, 461 – 469 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dei Tos AP . A current perspective on the role for molecular studies in soft tissue tumor pathology . Semin. Diagn. Pathol.30, 375 – 381 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Donsbeck A-V , RanchereD, CoindreJ-M, Le GallF, CordierJ-F, LoireR . Primary cardiac sarcomas: an immunohistochemical and grading study with long-term follow-up of 24 cases . Histopathology34, 295 – 304 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Orlandi A , SpagnoliLG . Novelties in immunoistochemical and molecular study of cardiac tumors . In : Cardiac Tumor Pathology . BassoC, ValenteML, ThieneG ( Eds ). Springer (Humana Press), New York, NY, USA, 183 – 193 ( 2013 ).
   Google Scholar
• Basso C , StefaniA, CalabreseF, FasoliG, ValenteM . Primary right atrial fibrosarcoma diagnosed by endocardial biopsy . Am. Heart J.131, 399 – 402 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Cornelis F , SilkM, SchoderHet al. Performance of intra-procedural 18-fluorodeoxyglucose PET/CT- guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities . Eur. J. Nucl. Med. Mol. Imaging41 ( 12 ), 2265 – 2272 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Miguel CE , BestettiRB . Primary cardiac lymphoma . Int. J. Cardiol.149, 358 – 363 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ray-Coquard I , MontescoMC, CoindreJMet al. Conticanet group. Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions . Ann. Oncol.23, 2442 – 2449 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lestuzzi C , SpinaM, MartellottaF, CarboneA . Massive myocardial infiltration by HIV-related non-Hodgkin lymphoma: echocardiographic aspects at diagnosis and at follow-up . J. Cardiovasc. Med. (Hagerstown).13, 836 – 838 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Flowers CR , SinhaR, VoseJM . Improving outcomes for patients with diffuse large B-cell lymphoma . CA Cancer J. Clin.60, 393 – 408 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Tilly H , DreylingM . ESMO Guidelines Working Group . Diffuse large B-cell non-Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up . Ann. Oncol.21 ( Suppl. 5 ), v172 – v174 ( 2010 ).
   PubMedGoogle Scholar
• Llombart-Cussac A , PivotX, ContessoGet al. Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience . Br. J. Cancer78, 1624 – 1628 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Debourdeau P , GligorovJ, TeixeiraL, AlettiM, ZammitC . Tumeurs cardiaques malignes . Bull. Cancer91, S136 – S146 ( 2004 ).
   PubMedGoogle Scholar
• Simpson L , KumarSK, OkunoSHet al. Malignant primary cardiac tumors. Review of a single institution experience . Cancer112, 2440 – 2446 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kim CH , DancerJY, CoffeyDet al. Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10 year single institution experience . Hum. Pathol.39, 933 – 938 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Agaimy A , RöschJ, WeyandM, StreckerT . Primary and metastatic cardiac sarcomas: a 12 year experience at a German heart center . Int. J. Clin. Exp. Pathol.5, 928 – 938 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Truong PT , JonesSO, MartensBet al. Treatment and outcomes in adult patients with primary cardiac sarcoma: the British Columbia Cancer Agency experience . Ann. Surg. Oncol.16, 3358 – 3365 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hamidi M , MoodyJS, WeigelTL, KozakKR . Primary cardiac sarcoma . Ann. Thorac. Surg.90, 176 – 181 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Grimer R , JudsonI, PeakeD, SeddonB . Guidelines for the management of soft tissue sarcomas . Sarcoma2010, 506182 ( 2010 ).
   PubMedGoogle Scholar
• Stucky CC , WasifN, AshmanJB, PockajBA, GundersonLL, GrayRJ . Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma . J. Surg. Oncol.109, 798 – 803 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Le Cesne A , OualiM, LeahyMGet al. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC Phase III clinical trials . Ann. Oncol.25 ( 12 ), 2425 – 2432 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mayer F , AebertH, RudertMet al. Primary malignant sarcomas of the heart and great vessels in adult patients. A single-center experience . Oncologist12, 1134 – 1142 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Vaporciyan A , ReardonMJ . Right heart sarcomas . Methodist Debakey Cardiovasc. J.6, 44 – 48 ( 2010 ).
   PubMedGoogle Scholar
• Putnam JB , SweeneyMS, ColonR, LanzaLA, FrazierOH, CooleyDA . Primary cardiac sarcomas . Ann. Thorac. Surg.51, 906 – 910 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Stefanovski PD , BidoliE, De PaoliAet al. Prognostic factors in soft tissue sarcomas: a study of 395 patients . Eur. J. Surg. Oncol.28, 153 – 164 ( 2002 ).
   PubMedGoogle Scholar
• Tsukushi S , NishidaY, UrakawaH, KozawaE, IshiguroN . Prognostic significance of histological invasion in high grade soft tissue sarcomas . Springerplus3, 544 ( 2014 ).
   PubMedGoogle Scholar
• Blackmon SH , RiceDC, CorreaAMet al. Management of primary pulmonary artery sarcomas . Ann. Thorac. Surg.87 ( 3 ), 977 – 984 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Rice DC , ReardonMJ . Left heart sarcomas . Methodist Debakey Cardiovasc. J.6, 49 – 56 ( 2010 ).
   PubMedGoogle Scholar
• Ramlawi B , Al-JabbariO, BlauLNet al. Autotransplantation for the resection of complex left heart tumors . Ann. Thorac. Surg.98, 863 – 868 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Patel SR , Vadhan-RajS, PapadopolousNet al. High-dose ifosfamide in bone and soft-tissue sarcomas: results of Phase II and pilot studies-dose response and schedule dependence . J. Clin. Oncol.15, 2378 – 2384 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA , DugganST, KeatingGM . Pegylated liposomal doxorubicin: a guide to its use in various malignancies . BioDrugs27, 533 – 540 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Grenader T , GoldbergA, Hadas-HalperinI, GabizonA . Long-term response to pegylated liposomal doxorubicin in patients with metastatic soft tissue sarcomas . Anticancer Drugs20, 15 – 20 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• D’Incalci M , BadriN, GalmariniCM, AllavenaP . Trabectedin, a drug acting on both cancer cells and the tumour microenvironment . Br. J. Cancer111, 646 – 650 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Leporini C , PatanèM, SaulloFet al. A comprehensive safety evaluation of trabectedin and drug–drug interactions of trabectedin-based combinations . BioDrugs28 ( 6 ), 499 – 511 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ganjoo K , JacobsC . Antiangiogenesis agents in the treatment of soft tissue sarcomas . Cancer116 ( 5 ), 1177 – 1183 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Penel N , MarréaudS, RobinYM, HohenbergerP . Angiosarcoma: state of the art and perspectives . Crit. Rev. Oncol. Hematol.80, 257 – 263 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• van der Graaf WT , BlayJY, ChawlaSPet al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled Phase 3 trial . Lancet379, 1879 – 1886 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Schlemmer M , ReichardtP, VerweijJet al. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group . Eur. J. Cancer44, 2433 – 2436 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kopp HG , PatelS, BrücherB, HartmannJT . Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma . Am. J. Clin. Dermatol.9 ( 4 ), 207 – 217 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Schöffski P , CornillieJ, WozniakA, LiH, HompesD . Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease . Oncol. Res. Treat.37, 355 – 362 ( 2014 ).
   PubMedGoogle Scholar
• Basavaraju SR , EasterlyCE . Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications . Med. Phys.29, 2391 – 2403 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Thariat J , Clément-ColmouK, VoginGet al. Radiation therapy of cardiac sarcomas . Cancer Radiother.18, 125 – 131 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Isambert N , Ray-CoquardI, ItalianoAet al. Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group . Eur. J. Cancer50, 128 – 136 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lestuzzi C , BuonadonnaA, ScaloneSet al. Feasibility of multimodality treatment for cardiac sarcomas . Presented at : European Society of Cardiology Congress . Barcelona, Spain, 30 August – 3 September 2014 .
   Google Scholar
• Li H , XuD, ChenZet al. Prognostic analysis for survival after resections of localized primary cardiac sarcomas: a single-institution experience . Ann. Thorac. Surg.97, 1379 – 1385 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Blackmon SH , ReardonMJ . Pulmonary artery sarcoma . Methodist Debakey Cardiovasc. J.6, 38 – 43 ( 2010 ).
   PubMedGoogle Scholar
• Wang M , FuG, JiangH, ZengK, HuaP . Multimodality treatment for cardiac angiosarcoma . Intern. Med.53, 1949 – 1953 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Burke AP , CowanD, VirmaniR . Primary sarcomas of the heart . Cancer69, 387 – 395 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Bakaeen FG , JaroszewskiDE, RiceDCet al. Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era . J. Thorac. Cardiovasc. Surg.137, 1454 – 1460 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Randhawa JS , BuddGT, RandhawaMet al. Primary cardiac sarcoma: 25-year cleveland clinic experience . Am. J. Clin. Oncol. doi: https://doi.org/10.1097/COC.0000000000000106 ( 2014 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Ravi V , BenjaminRS . Systemic therapy for cardiac sarcomas . Methodist Debakey Cardiovasc. J.6, 57 – 60 ( 2010 ).
   PubMedGoogle Scholar